ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07148
0,05%
Bitcoin
61.979,28
0,29%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IDEXX Laboratories Inc (IDXX)

  7. IDEXX Laboratories Inc (IDXX) News

IDXX

IDEXX Laboratories (IDXX)

IDEXX Laboratories Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IDXX
DatumZeitQuelleÜberschriftSymbolFirma
24/06/202417h00Business WireIDEXX Laboratories to Release 2024 Second Quarter Financial ResultsNASDAQ:IDXXIDEXX Laboratories Inc
04/06/202413h00PR Newswire (US)IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing PancreatitisNASDAQ:IDXXIDEXX Laboratories Inc
04/06/202413h00PR Newswire (Canada)IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing PancreatitisNASDAQ:IDXXIDEXX Laboratories Inc
31/05/202422h00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:IDXXIDEXX Laboratories Inc
20/05/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
17/05/202421h49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
14/05/202420h00Business WireIDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor DayNASDAQ:IDXXIDEXX Laboratories Inc
10/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/05/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
01/05/202412h30Business WireIDEXX Laboratories Announces First Quarter ResultsNASDAQ:IDXXIDEXX Laboratories Inc
04/04/202422h30Business WireIDEXX Laboratories to Release 2024 First Quarter Financial ResultsNASDAQ:IDXXIDEXX Laboratories Inc
07/03/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
07/03/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
06/03/202423h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
05/03/202423h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
04/03/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
22/02/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
20/02/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
20/02/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
20/02/202420h00Business WireIDEXX Laboratories to Present at Two Upcoming Institutional Investor ConferencesNASDAQ:IDXXIDEXX Laboratories Inc
16/02/202423h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
 Showing the most relevant articles for your search:NASDAQ:IDXX

Kürzlich von Ihnen besucht

BIT
S27465
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten